Recro Pharma CFO Ryan Lake's 2021 pay jumps 622% to $2.3M
Recro Pharma reports 2021 executive compensation
By ExecPay News
Published: April 1, 2022
Recro Pharma reported fiscal year 2021 executive compensation information on April 1, 2022.
In 2021, two executives at Recro Pharma received on average a compensation package of $1.7M, a 39% increase compared to previous year.
Average pay of disclosed executives at Recro Pharma
Ryan D. Lake, Chief Financial Officer, received $2.3M in total, which increased by 7% compared to 2020. 37% of Lake's compensation, or $868K, was in stock awards. Lake also received $243K in non-equity incentive plan, $744K in option awards, $425K in salary, as well as $49K in other compensation.
J. David Enloe, Jr, Chief Executive Officer, received a compensation package of $1.1M, which increased by 2% compared to previous year. 50% of the compensation package, or $550K, was in salary.
Related executives
You may also like
Source: SEC filing on April 1, 2022.